Company intelligence / Profile preview
CCM Biosciences
Mount Laurel, New Jersey, USAccm-bio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
CCM Biosciences has advanced more than ten first-in-class drug candidates across oncology, rare genetic disorders, autoimmune conditions, and age-related diseases. Notable achievements include the discovery of first-in-class activators for previously undruggable targets like SIRT3. Several programs have reached significant preclinical milestones with plans to file INDs soon; early clinical results are being presented at major conferences such as ASCO 2025.
- Therapeutic areas
- ImmunologyOncologyRare DiseasesNeurology
- Modalities
- Small moleculesGene therapiesBiologics (biopharmaceuticals)Nanomedicines
- Industry
- Biotech
02
Drug pipeline
12 assets11 more assets in the full pipeline.
Request access →03
Partnerships
PMC Group – strategic partnership providing integrated CMC/manufacturing support.Academic collaborations with Wistar InstituteVanderbilt University Medical SchoolThomas Jefferson UniversityCleveland Clinic Taussig Cancer InstituteUCLAYale UniversityUniversity of PalermoItalian Cystic Fibrosis Foundation
Beyond the preview
Go deeper on CCM Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CCM Biosciences.